Further evidence that peptide histidine isoleucine (PHI) may function as a prolactin releasing factor in rats
- 1 July 1985
- Vol. 6 (4) , 709-712
- https://doi.org/10.1016/0196-9781(85)90176-7
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education
- Ministry of Health, Labour and Welfare
This publication has 15 references indexed in Scilit:
- Peptide histidine isoleucine- and vasoactive intestinal polypeptide-like immunoreactivity coexist in rat hypophysial portal bloodNeuroscience Letters, 1983
- Prolactin-releasing activity of porcine intestinal peptide (PHI-27)Peptides, 1983
- Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27Nature, 1983
- Effects of VIP, TRH, GABA and dopamine on prolactin release from superfused rat anterior pituitary cellsLife Sciences, 1983
- Effect of the Peptide PHI-27 on Prolactin Release in vitroNeuroendocrinology, 1983
- PHI, a VIP-like peptide, is present in the rat median eminenceActa Physiologica Scandinavica, 1982
- Stimulation of prolactin secretion in the rat by α-neo-endorphin, β-neo-endorphin and dynorphinBiochemical and Biophysical Research Communications, 1982
- Vasoactive Intestinal Peptide: Evidence for a Hypothalamic Site of Action to Release Growth Hormone, Luteinizing Hormone, and Prolactin in Conscious Ovariectomized Rats*Endocrinology, 1979
- Stimulation of prolactin release by vasoactive intestinal peptide (VIP)European Journal of Pharmacology, 1978
- Prolactin Release by Vasoactive Intestinal Polypeptide in Rats*Endocrinology, 1978